{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:48:59Z","timestamp":1762508939042},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,16]]},"DOI":"10.7759\/cureus.35042","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T08:01:05Z","timestamp":1676534465000},"source":"Crossref","is-referenced-by-count":1,"title":["IL-6 Serum Levels in COVID-19 Patients With Vertigo"],"prefix":"10.7759","author":[{"given":"Dimitrios","family":"Kitsos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Tzartos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Korres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasileios","family":"Giannopapas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Riga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Stergiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthi","family":"Tsoga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Grigoropoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Paraskevas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Zompola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Nikolopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sotirios","family":"Giannopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Hearing Loss, Tinnitus, and Dizziness in COVID-19: A Systematic Review and Meta-Analysis","author":"Jafari Z","unstructured":"Jafari Z, Kolb BE, Mohajerani MH. Hearing Loss, Tinnitus, and Dizziness in COVID-19: A Systematic Review and Meta-Analysis. Cambridge Core. Cambridge University Press, 2022;"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/0145561320959573","article-title":"Dizziness and COVID-19","volume":"100","author":"Saniasiaya J","year":"2021","unstructured":"Saniasiaya J, Kulasegarah J. Dizziness and COVID-19. Ear Nose Throat J. 2021, 100:29-30. 10.1177\/0145561320959573","journal-title":"Ear Nose Throat J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/17590914211057635","article-title":"Covid-19-Induced Dysautonomia: A Menace of Sympathetic Storm","author":"Al-Kuraishy HM","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Qusti S, Alshammari EM, Gyebi GA, Batiha GE. Covid-19-Induced Dysautonomia: A Menace of Sympathetic Storm. ASN Neuro. 2021. 13:17590914211057635. 10.1177\/17590914211057635"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.790931","article-title":"Acute vertigo after COVID-19 vaccination: Case series and literature review","volume":"8","author":"Di Mauro P","year":"2021","unstructured":"Di Mauro P, La Mantia I, Cocuzza S, et al.. Acute vertigo after COVID-19 vaccination: Case series and literature review. Front Med (Lausanne). 2021, 8:790931. 10.3389\/fmed.2021.790931","journal-title":"Front Med (Lausanne)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/audiolres11030039","article-title":"Benign paroxysmal positional vertigo (BPPV) in COVID-19","volume":"11","author":"Picciotti PM","year":"2021","unstructured":"Picciotti PM, Passali GC, Sergi B, De Corso E. Benign paroxysmal positional vertigo (BPPV) in COVID-19. Audiol Res. 2021, 11:418-22. 10.3390\/audiolres11030039","journal-title":"Audiol Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5152\/iao.2015.1412","article-title":"The Role of Oxidative Stress and Inflammatory Mediators in Benign Paroxysmal Positional Vertigo","author":"G\u00fc\u00e7l\u00fct\u00fcrk MT","year":"2016","unstructured":"G\u00fc\u00e7l\u00fct\u00fcrk MT, \u00dcnal ZN, \u0130smi O, \u00c7imen MB, \u00dcnal M. The Role of Oxidative Stress and Inflammatory Mediators in Benign Paroxysmal Positional Vertigo. J Int Adv Otol. 2016. 12:101-5. 10.5152\/iao.2015.1412"},{"key":"ref7","article-title":"Serum oxidative stress, inflammatory response and platelet activation in patients with vascular vertigo","volume":"33","author":"Qian SX","year":"2019","unstructured":"Qian SX, Gu JX, Guan QB, Zhang XL, Wang YP. Serum oxidative stress, inflammatory response and platelet activation in patients with vascular vertigo. J Biol Regul Homeost Agents. 2019, 33:499-504.","journal-title":"J Biol Regul Homeost Agents"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-23911-4","article-title":"Proinflammatory cytokines and response to molds in mononuclear cells of patients with Meniere disease","volume":"8","author":"Frejo L","year":"2018","unstructured":"Frejo L, Gallego-Martinez A, Requena T, et al.. Proinflammatory cytokines and response to molds in mononuclear cells of patients with Meniere disease. Sci Rep. 2018, 8:5974. 10.1038\/s41598-018-23911-4","journal-title":"Sci Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01446","article-title":"The COVID-19 cytokine storm; what we know so far","volume":"11","author":"Ragab D","year":"2020","unstructured":"Ragab D, Salah Eldin H, Taeimah M, Khattab R, Salem R. The COVID-19 cytokine storm; what we know so far. Front Immunol. 2020, 11:1446. 10.3389\/fimmu.2020.01446","journal-title":"Front Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2020.05.009","article-title":"IL-6: Relevance for Immunopathology of SARS-CoV-2","author":"Gubernatorova EO","year":"2020","unstructured":"Gubernatorova EO, Gorshkova EA, Polinova AI, Drutskaya MS. IL-6: Relevance for Immunopathology of SARS-CoV-2. Cytokine Growth Factor Rev. 2020. 53:13-24. 10.1016\/j.cytogfr.2020.05.009"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmal.2020.04.002","article-title":"Interleukin-6 as a potential biomarker of COVID-19 progression","volume":"50","author":"Ulhaq ZS","year":"2020","unstructured":"Ulhaq ZS, Soraya GV. Interleukin-6 as a potential biomarker of COVID-19 progression. Med Mal Infect. 2020, 50:382-3. 10.1016\/j.medmal.2020.04.002","journal-title":"Med Mal Infect"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0312-7","article-title":"COVID-19: risk for cytokine targeting in chronic inflammatory diseases?","volume":"20","author":"Schett G","year":"2020","unstructured":"Schett G, Sticherling M, Neurath MF. COVID-19: risk for cytokine targeting in chronic inflammatory diseases?. Nat Rev Immunol. 2020, 20:271-2. 10.1038\/s41577-020-0312-7","journal-title":"Nat Rev Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.03006-2020","article-title":"Confronting the Controversy: Interleukin-6 and the COVID-19 Cytokine Storm Syndrome","author":"Chen LY","year":"2020","unstructured":"Chen LY, Hoiland RL, Stukas S, Wellington CL, Sekhon MS. Confronting the Controversy: Interleukin-6 and the COVID-19 Cytokine Storm Syndrome. 2020. 10.1183\/13993003.03006-2020"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.110213","article-title":"SARS-CoV-2-mediated encephalitis: Role of AT2R receptors in the blood-brain barrier","volume":"144","author":"de Sousa AK","year":"2020","unstructured":"de Sousa AK, Magalh\u00e3es DA, Ferreira JD, Barbosa AL. SARS-CoV-2-mediated encephalitis: Role of AT2R receptors in the blood-brain barrier. Med Hypotheses. 2020, 144:110213. 10.1016\/j.mehy.2020.110213","journal-title":"Med Hypotheses"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100663","article-title":"The IL-1\u03b2, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19","volume":"3","author":"Schulthei\u00df C","year":"2022","unstructured":"Schulthei\u00df C, Willscher E, Paschold L, et al.. The IL-1\u03b2, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep Med. 2022, 3:100663. 10.1016\/j.xcrm.2022.100663","journal-title":"Cell Rep Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.956515","article-title":"Vestibular disorders in patients after COVID-19 infection","volume":"13","author":"Pazdro-Zastawny K","year":"2022","unstructured":"Pazdro-Zastawny K, Dorobisz K, Misiak P, Kruk-Krzemie\u0144 A, Zato\u0144ski T. Vestibular disorders in patients after COVID-19 infection. Front Neurol. 2022, 13:956515. 10.3389\/fneur.2022.956515","journal-title":"Front Neurol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.27287.2","article-title":"'The long tail of Covid-19' - The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients","volume":"9","author":"Doykov I","year":"2020","unstructured":"Doykov I, H\u00e4llqvist J, Gilmour KC, Grandjean L, Mills K, Heywood WE. 'The long tail of Covid-19' - The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. F1000Res. 2020, 9:1349. 10.12688\/f1000research.27287.2","journal-title":"F1000Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.884002","article-title":"Self-reported tinnitus and vertigo or dizziness in a cohort of adult long COVID patients","volume":"13","author":"Degen CV","year":"2022","unstructured":"Degen CV, Mikuteit M, Niewolik J, et al.. Self-reported tinnitus and vertigo or dizziness in a cohort of adult long COVID patients. Front Neurol. 2022, 13:884002. 10.3389\/fneur.2022.884002","journal-title":"Front Neurol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1177\/20406223221076890","article-title":"Neurological manifestations of long-COVID syndrome: a narrative review","volume":"13","author":"Stefanou MI","year":"2022","unstructured":"Stefanou MI, Palaiodimou L, Bakola E, et al.. Neurological manifestations of long-COVID syndrome: a narrative review. Ther Adv Chronic Dis. 2022, 13:20406223221076890. 10.1177\/20406223221076890","journal-title":"Ther Adv Chronic Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/132160-il-6-serum-levels-in-covid-19-patients-with-vertigo","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:53:32Z","timestamp":1707508412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/132160-il-6-serum-levels-in-covid-19-patients-with-vertigo"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.35042","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,16]]}}}